By interacting directly with NSCLC cell Smad family members (Smad2, Smad3, and Smad4), MELK inhibits EMT and increases tumor cell motility, invasion, and metastasis (Cheng et al. 2017). Here, MELK is linked to non-small cell lung carcinoma.